Clinical Trials Directory

Trials / Unknown

UnknownNCT04890418

Risk Factors and Prevention of Severe Pain Upon Cessation of a Peripheral Nerve Block

Risk Factors and Prevention of Severe Pain Upon Cessation of a Peripheral Nerve Block. A Prospective Randomized Study in Ambulatory Patients Undergoing Upper Limb Bone Surgery Under Single Shot Axillary Plexus Block

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Risk factors and Prevention of severe Pain upon cessation of a peripheral nerve block. A prospective randomized study in ambulatory patients undergoing upper limb bone surgery under single shot axillary plexus block.

Detailed description

Pain in the course of upper limb bone surgery is a major source of discomfort for patients during postoperative time. Severe post-operative pain is a risk factor for chronic pain. Use of a well-known molecule, regularly used in anesthesiology. Prospective double-blind study on 120 patients. Pain rebound upon awakening of the axillary plexus during upper limb bone surgery is a frequent phenomenon in post-operative follow-up of patients. The anti-hyperalgesic properties of ketamine could be a benefit against this effect. No studies have combined intravenous ketamine with localoregional anesthesia to reduce pain upon its release. This may improve patients' post-operative comfort. The patients will be randomized in 2 groups and allocated to receive (slow intravenous injection) either 0.3 mg/kg intravenous ketamine diluted into 10mL saline or 10 mL 0.9% saline after the realization of PNB, before tourniquet set up and beginning of surgery.

Conditions

Interventions

TypeNameDescription
DRUGKetalar, 5 mg/mL Injectable SolutionThe patients will receive (slow intravenous injection) 0.3 mg/kg intravenous ketamine diluted by the pharmacy department into 10mL saline after the realization of PNB but before tourniquet set up and before start of surgery.
OTHERPlaceboThe patients will receive 10 mL of 0.9% saline. This injection is also performed after the realization of PNB but before tourniquet set up and before start of surgery.

Timeline

Start date
2020-01-01
Primary completion
2021-05-31
Completion
2021-07-01
First posted
2021-05-18
Last updated
2021-05-18

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04890418. Inclusion in this directory is not an endorsement.